IBDEI13G ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19304,0)
 ;;=593.9^^105^1230^9
 ;;^UTILITY(U,$J,358.3,19304,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19304,1,4,0)
 ;;=4^593.9
 ;;^UTILITY(U,$J,358.3,19304,1,5,0)
 ;;=5^Chronic Renal Insufficiency
 ;;^UTILITY(U,$J,358.3,19304,2)
 ;;=Chronic Renal Insufficiency^123849
 ;;^UTILITY(U,$J,358.3,19305,0)
 ;;=581.9^^105^1230^37
 ;;^UTILITY(U,$J,358.3,19305,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19305,1,4,0)
 ;;=4^581.9
 ;;^UTILITY(U,$J,358.3,19305,1,5,0)
 ;;=5^Nephrotic Syndrome
 ;;^UTILITY(U,$J,358.3,19305,2)
 ;;=^82357
 ;;^UTILITY(U,$J,358.3,19306,0)
 ;;=753.12^^105^1230^43
 ;;^UTILITY(U,$J,358.3,19306,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19306,1,4,0)
 ;;=4^753.12
 ;;^UTILITY(U,$J,358.3,19306,1,5,0)
 ;;=5^Polycystic Kidney Disease
 ;;^UTILITY(U,$J,358.3,19306,2)
 ;;=^67295
 ;;^UTILITY(U,$J,358.3,19307,0)
 ;;=791.0^^105^1230^45
 ;;^UTILITY(U,$J,358.3,19307,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19307,1,4,0)
 ;;=4^791.0
 ;;^UTILITY(U,$J,358.3,19307,1,5,0)
 ;;=5^Proteinuria
 ;;^UTILITY(U,$J,358.3,19307,2)
 ;;=Proteinuria^99873
 ;;^UTILITY(U,$J,358.3,19308,0)
 ;;=791.9^^105^1230^48
 ;;^UTILITY(U,$J,358.3,19308,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19308,1,4,0)
 ;;=4^791.9
 ;;^UTILITY(U,$J,358.3,19308,1,5,0)
 ;;=5^Pyuria
 ;;^UTILITY(U,$J,358.3,19308,2)
 ;;=^273408
 ;;^UTILITY(U,$J,358.3,19309,0)
 ;;=592.0^^105^1230^49
 ;;^UTILITY(U,$J,358.3,19309,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19309,1,4,0)
 ;;=4^592.0
 ;;^UTILITY(U,$J,358.3,19309,1,5,0)
 ;;=5^Renal Calculi
 ;;^UTILITY(U,$J,358.3,19309,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,19310,0)
 ;;=403.91^^105^1230^50
 ;;^UTILITY(U,$J,358.3,19310,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19310,1,4,0)
 ;;=4^403.91
 ;;^UTILITY(U,$J,358.3,19310,1,5,0)
 ;;=5^Renal Failure, Chronic Hypertensive
 ;;^UTILITY(U,$J,358.3,19310,2)
 ;;=^269610
 ;;^UTILITY(U,$J,358.3,19311,0)
 ;;=586.^^105^1230^53
 ;;^UTILITY(U,$J,358.3,19311,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19311,1,4,0)
 ;;=4^586.
 ;;^UTILITY(U,$J,358.3,19311,1,5,0)
 ;;=5^Uremia
 ;;^UTILITY(U,$J,358.3,19311,2)
 ;;=Uremia^104733
 ;;^UTILITY(U,$J,358.3,19312,0)
 ;;=599.0^^105^1230^65
 ;;^UTILITY(U,$J,358.3,19312,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19312,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,19312,1,5,0)
 ;;=5^Urinary Tract Infection
 ;;^UTILITY(U,$J,358.3,19312,2)
 ;;=Urinary Tract Infection^124436
 ;;^UTILITY(U,$J,358.3,19313,0)
 ;;=275.42^^105^1230^28
 ;;^UTILITY(U,$J,358.3,19313,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19313,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,19313,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,19313,2)
 ;;=Hypercalcemia^59932
 ;;^UTILITY(U,$J,358.3,19314,0)
 ;;=275.41^^105^1230^31
 ;;^UTILITY(U,$J,358.3,19314,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19314,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,19314,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,19314,2)
 ;;=Hypocalcemia^60542
 ;;^UTILITY(U,$J,358.3,19315,0)
 ;;=276.7^^105^1230^29
 ;;^UTILITY(U,$J,358.3,19315,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19315,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,19315,1,5,0)
 ;;=5^Hyperkalemia/Hyperpotassemia
 ;;^UTILITY(U,$J,358.3,19315,2)
 ;;=Hyperkalemia/Hyperpotassemia^60042
 ;;^UTILITY(U,$J,358.3,19316,0)
 ;;=276.8^^105^1230^32
 ;;^UTILITY(U,$J,358.3,19316,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19316,1,4,0)
 ;;=4^276.8
 ;;^UTILITY(U,$J,358.3,19316,1,5,0)
 ;;=5^Hypokalemia/Hypopotassemia
 ;;^UTILITY(U,$J,358.3,19316,2)
 ;;=Hypokalemia/Hypopotassemia^60611
 ;;^UTILITY(U,$J,358.3,19317,0)
 ;;=275.2^^105^1230^26
 ;;
 ;;$END ROU IBDEI13G
